Intervention Review

Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis

  1. Judith Thornton1,*,
  2. Satyapal Rangaraj2

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 12 SEP 2012

Assessed as up-to-date: 11 JUL 2012

DOI: 10.1002/14651858.CD007336.pub3

How to Cite

Thornton J, Rangaraj S. Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis. Cochrane Database of Systematic Reviews 2012, Issue 9. Art. No.: CD007336. DOI: 10.1002/14651858.CD007336.pub3.

Author Information

  1. 1

    University of Manchester, School of Community-based Medicine, Manchester, UK

  2. 2

    Queens Medical Centre, Children's Services, Nottingham, UK

*Judith Thornton, School of Community-based Medicine, University of Manchester, 5th Floor, Williamson Building, Oxford Road, Manchester, M13 9PT, UK. judith.thornton@nice.org.uk. judith.thornton@manchester.ac.uk.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 12 SEP 2012

SEARCH

  1. Current Version

    Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis

    Judith Thornton and Satyapal Rangaraj

    Article first published online: 12 SEP 2012 | DOI: 10.1002/14651858.CD007336.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis

    Judith Thornton and Satyapal Rangaraj

    Article first published online: 21 JAN 2009 | DOI: 10.1002/14651858.CD007336.pub2

  2. Version 1

    Disease modifying anti-rheumatic drugs in people with cystic fibrosis-related arthritis

    Judith Thornton and Satyapal Rangaraj

    Article first published online: 16 JUL 2008 | DOI: 10.1002/14651858.CD007336